Hera Therapeutics Inc.

New Filing
CIK: 0001563355·Biotechnology·DELAWARE·Filed: Jun 11, 2015
Total Offering

$15,969,973

Amount Sold

$8,907,483

Investors

26

First Sale

May 27, 2015

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2012
Non-Accredited Investors
No

Related Persons

NameRole
John Sayward
Related Person
Michael Cannon
Related Person
William Respess
Related Person
Wende Hutton
Related Person
David Kabakoff
Related Person
Steven James
Related Person

Company

Antiva Biosciences, Inc.

3210 Merryfield Row

San Diego, CA, 92121

8583425556

SEC Filing

0001563355-15-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free